Close



Apr 10, 2024 04:59PM
Jan 30, 2024 07:03AM
Jan 30, 2024 07:00AM
Jan 8, 2024 12:12PM
Dec 27, 2023 05:05PM
Sep 25, 2023 08:35AM
Sep 25, 2023 08:34AM Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss
Aug 9, 2023 07:32AM
Aug 9, 2023 07:30AM
May 4, 2023 06:30AM
Mar 24, 2023 08:49AM
Feb 3, 2023 06:30AM
Nov 3, 2022 06:30AM
Sep 16, 2022 07:16AM Regeneron (REGN) and Intellia (NTLA) Report Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001
Sep 16, 2022 07:15AM
Sep 16, 2022 07:15AM
Aug 4, 2022 10:21AM
Aug 3, 2022 06:30AM
Jul 1, 2022 07:00AM
Jun 2, 2022 07:31AM
Jun 2, 2022 07:30AM Regeneron Strengthens Commitment to Oncology through Purchase of Sanofi's Stake in the Regeneron and Sanofi Collaboration on Libtayo® (cemiplimab), a PD-1 Inhibitor Approved for Multiple Forms of Can
Jun 2, 2022 01:00AM
May 31, 2022 08:36AM
May 31, 2022 08:31AM
May 4, 2022 06:30AM
Apr 19, 2022 12:59PM
Apr 19, 2022 09:24AM
Apr 19, 2022 08:48AM BMO Capital Reiterates Outperform Rating, $780 Price Target on Regeneron Pharma (REGN) Following Checkmate (CMPI) Acquisition
Apr 19, 2022 07:58AM
Apr 19, 2022 07:00AM
Apr 19, 2022 07:00AM
Apr 19, 2022 07:00AM
Apr 19, 2022 07:00AM
Aug 6, 2021 09:22AM
Aug 5, 2021 06:19PM After-Hours Stock Movers 08/05: (GRPN) (CSOD) (CVNA) Higher; (DRNA) (ZNGA) (NVAX) Lower (more...)
May 6, 2021 06:30AM
Feb 11, 2021 02:01PM
Feb 11, 2021 02:00PM
Feb 5, 2021 06:30AM
Jan 12, 2021 05:45PM
Jan 12, 2021 05:45PM
Oct 9, 2020 04:50PM U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment
Oct 5, 2020 09:30AM
Jun 23, 2020 07:10AM
Nov 24, 2019 04:00PM
Jun 26, 2019 01:30PM
Jun 26, 2019 01:30PM
Jun 26, 2019 01:30PM
Jun 26, 2019 01:29PM FDA Approves Dupixent® (dupilumab) for Chronic Rhinosinusitis with Nasal Polyposis
Feb 25, 2019 04:58PM

923,804 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All